GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $97.67.
Several research firms recently issued reports on GEHC. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Finally, Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th.
View Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Price Performance
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Equities analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current year.
Hedge Funds Weigh In On GE HealthCare Technologies
Several hedge funds and other institutional investors have recently made changes to their positions in GEHC. LGT Financial Advisors LLC increased its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares during the last quarter. CoreFirst Bank & Trust acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $25,000. Capital Performance Advisors LLP acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at $26,000. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $26,000. Finally, Runnymede Capital Advisors Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $28,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- Using the MarketBeat Dividend Yield Calculator
- Buffett’s on the Sidelines – Should You Follow?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- How to Calculate Inflation Rate
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.